Across TCGA pan-cancer cohorts, RN7SKP261 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RN7SKP261’s most consistent transcriptional readouts.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where RN7SKP261 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SKP261 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

BLCA, LUAD, and LUSC are the cancer types where RN7SKP261 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SKP261 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BLCA	All	All	+0.110	.034	2	view →
LUAD	All	All	−0.070	.014	2	view →
LUSC	Male	All	−0.048	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RN7SKP261 RNA expression & survival · all RN7SKP261 data types